Learning Therapeutic Lessons from Metastasis Suppressor Proteins

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2009 Feb 27

PMID 19242414

Citations 90

Authors

Steven Christopher Smith

Dan Theodorescu

Affiliations

Soon will be listed here.

Abstract

Metastasis suppressor proteins regulate multiple steps in the metastatic cascade, including cancer cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. Understanding the biology of metastasis suppressors provides valuable mechanistic insights that may translate to therapeutic opportunities. Several reports have explored novel strategies for restoring metastasis suppressor function, including gene transfer, induction of previously suppressed gene expression and exogenous administration of gene product. Pathways activated downstream of metastasis suppressor loss can also be targeted. Although none of these strategies are yet in routine clinical use, several are being tested preclinically and in clinical trials.

Citing Articles

TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis.

Lee Y, Ko D, Yoon J, Kim S J Transl Med. 2025; 23(1):146.

PMID: 40025509 PMC: 11874797. DOI: 10.1186/s12967-025-06075-4.

An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor.

Subramaniyam K, Harihar S Cell Biochem Biophys. 2024; 82(2):399-409.

PMID: 38355846 DOI: 10.1007/s12013-024-01227-7.

Metastasis suppressor genes in clinical practice: are they druggable?.

Gelman I Cancer Metastasis Rev. 2023; 42(4):1169-1188.

PMID: 37749308 PMC: 11629483. DOI: 10.1007/s10555-023-10135-w.

Mechanisms of action of NME metastasis suppressors - a family affair.

Prunier C, Chavrier P, Boissan M Cancer Metastasis Rev. 2023; 42(4):1155-1167.

PMID: 37353690 PMC: 10713741. DOI: 10.1007/s10555-023-10118-x.

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer.

Jiao Y, Li S, Gong J, Zheng K, Xie Y Front Oncol. 2023; 13:1134149.

PMID: 37064084 PMC: 10090471. DOI: 10.3389/fonc.2023.1134149.

References

Ichikawa T, Ichikawa Y, Dong J, Hawkins A, Griffin C, Isaacs W . Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res. 1992; 52(12):3486-90. View

Chen S, Hoehne F, Giuliano A . The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007; 14(12):3378-84. DOI: 10.1245/s10434-007-9513-6. View

Smith S, Nicholson B, Nitz M, Frierson Jr H, Smolkin M, Hampton G . Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination. Am J Pathol. 2009; 174(2):371-9. PMC: 2630547. DOI: 10.2353/ajpath.2009.080538. View

Eckhardt B, Parker B, van Laar R, Restall C, Natoli A, Tavaria M . Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res. 2005; 3(1):1-13. View

Fidler I . Selection of successive tumour lines for metastasis. Nat New Biol. 1973; 242(118):148-9. DOI: 10.1038/newbio242148a0. View

Leone A, Flatow U, King C, Sandeen M, Margulies I, Liotta L . Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991; 65(1):25-35. DOI: 10.1016/0092-8674(91)90404-m. View

Beach S, Tang H, Park S, Dhillon A, Keller E, Kolch W . Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene. 2007; 27(15):2243-8. PMC: 2933472. DOI: 10.1038/sj.onc.1210860. View

Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu N . The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 2005; 65(14):6042-53. PMC: 1360170. DOI: 10.1158/0008-5472.CAN-04-3043. View

Pelkey T, Frierson Jr H, Bruns D . Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem. 1996; 42(9):1369-81. View

10.

Kurdistani S, Arizti P, Reimer C, Sugrue M, Aaronson S, Lee S . Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 1998; 58(19):4439-44. View

11.

Wong C, Lee A, Shientag L, Yu J, Dong Y, Kao G . Apoptosis: an early event in metastatic inefficiency. Cancer Res. 2001; 61(1):333-8. View

12.

Alix-Panabieres C, Riethdorf S, Pantel K . Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res. 2008; 14(16):5013-21. DOI: 10.1158/1078-0432.CCR-07-5125. View

13.

Fidler I . Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970; 45(4):773-82. View

14.

Butler T, Gullino P . Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 1975; 35(3):512-6. View

15.

Theodorescu D, Sapinoso L, Conaway M, Oxford G, Hampton G, Frierson Jr H . Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res. 2004; 10(11):3800-6. DOI: 10.1158/1078-0432.CCR-03-0653. View

16.

Dong J, Lamb P, Rinker-Schaeffer C, Vukanovic J, Ichikawa T, Isaacs J . KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995; 268(5212):884-6. DOI: 10.1126/science.7754374. View

17.

Hu L, Zou H, Zhan S, Cao K . Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep. 2007; 17(6):1383-9. View

18.

Xu J, Guo X, Ren L, Shao L, Liu M . KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. World J Gastroenterol. 2008; 14(7):1126-32. PMC: 2689419. DOI: 10.3748/wjg.14.1126. View

19.

Subramanian C, Cotter 2nd M, Robertson E . Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med. 2001; 7(3):350-5. DOI: 10.1038/85499. View

20.

Reddy K, Nabha S, Atanaskova N . Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 2003; 22(4):395-403. DOI: 10.1023/a:1023781114568. View